48 CFR 27.204-1 – Use of patented technology under the United States-Mexico-Canada Agreement
Current as of: 2024 | Check for updates
|
Other versions
When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.
